Accolade Partners

Investor type

VC / Fund of funds

Founded

2000

AUM

$5 800 M

Location

Washington, District of Columbia, United States

Investment Ticket

$5-10 m

Investment Stage

Seed Series A Series B Late Stage (Series C+)

Region of investment

North America Asia
Investor profile last updated: 16 August, 2026

Profile

Accolade Partners is a venture capital and growth equity fund of funds headquartered in Washington, DC, and founded in 2000. The firm specializes in constructing concentrated portfolios of hard-to-access funds. Their team comprises deeply knowledgeable and cohesive members with a focus on building strong partnerships with their fund managers. Accolade seeks to provide differentiated exposure to their investors through their selectivity, discipline, and partnership approach.

Accolade invests in fund managers across technology and healthcare sectors, with a focus on venture capital, growth equity, and blockchain. They target seed and Series A managers as well as emerging managers, and implement a strategy to avoid dilution of returns while aiming for early liquidity in three to five years. Their empowerment funds further invest in managers from historically undercapitalized communities. Accolade manages its investments with a total firm-wide asset under management (AUM) strategy, seeking the best-of-breed managers for optimal returns.

The firm has made notable allocations in funds involved in high-growth software and emerging technology sectors, continuously supporting innovative strategies through their fund selections. Accolade Partners maintains strong relationships with top-tier managers to secure hard-to-access investment opportunities in varied technology and blockchain-focused sectors.

Industry

Blockchain/Crypto Transportation Software Security Robotics Marketing and Advertising Healthcare Services Foodtech Food and Beverage Fintech Edtech Education Technology HealthTech Web3

Accolade Partners Funds

Name Type
Questionare
Industry
Questionare
Stage
Questionare
Region
Size AUM Launch date
Accolade Partners IX, L.P.
Private Equity (PE)
Healthcare Services
Technology
Series A
Series B
Late Stage (Series C+)
North America
$5-10 m
$505 M
May 2023
Accolade Partners Growth III, L.P.
Private Equity (PE)
Healthcare Services
Technology
Series B
Late Stage (Series C+)
North America
$5-10 m
$400 M
December 2023
Accolade Partners Venture I, L.P.
Venture Capital (VC)
Healthcare Services
Technology
Pre-seed
Seed
North America
$5-10 m
$131 M
December 2023

Contacts

Name
Title
Email
avatar
Atul Rustgi Managing Partner
Managing Partner
a•••@•••
avatar
Joelle Kayden Managing Partner
Managing Partner
j•••@•••
Upgrade to see contacts
avatar
pBwveGTYmsWV9htZ pBwveGTYmsWV9htZ
pBwveGTYmsWV9htZ
avatar
pBwveGTYmsWV9htZ pBwveGTYmsWV9htZ
pBwveGTYmsWV9htZ
avatar
pBwveGTYmsWV9htZ pBwveGTYmsWV9htZ
pBwveGTYmsWV9htZ
Investment-team contacts for Accolade Partners — including verified work emails and LinkedIn profiles — are available to Private Equity List subscribers.
Instant access on the web. Plans from $129/month — see pricing.
Contacts sourced from the firm's website and LinkedIn, re-verified on a rolling cycle. Spot a stale contact, or none at all? Report it — we re-run that firm within 48h and get back to you.

FAQs about Accolade Partners

Accolade Partners is a venture capital firm that also operates as a fund of funds. It backs companies at Seed, Series A, Series B and Late Stage (Series C+), writing tickets of $5-10 m.
Accolade Partners is located in Washington, District of Columbia, United States.
Accolade Partners was founded in 2000.
Accolade Partners invests in companies and startups in Blockchain/Crypto, Transportation, Software, Security, Robotics, Marketing and Advertising, Healthcare Services, Foodtech, Food and Beverage, Fintech, Edtech, Education, Technology, HealthTech, Web3.
Accolade Partners invests in companies and startups in North America, Asia.
Accolade Partners invests in companies and startups at Seed, Series A, Series B, Late Stage (Series C+).
Accolade Partners usually invests $5-10 m on average.
Accolade Partners has around $5 800m assets under management.
Accolade Partners last fund was created/launched in 2023-12-11
Accolade Partners can be reached through its website accoladepartners.com, its LinkedIn page and its X account. Its general enquiries address is [email protected]. Cold-mailing a general inbox rarely reaches a partner, so Private Equity List also lists the investment-team contacts for Accolade Partners — names, roles, verified work emails and LinkedIn profiles — available on a Pro plan from $129/month (see pricing). Contacts are sourced from the firm's website and LinkedIn and re-verified on a rolling cycle. Spot a stale contact, or none at all? Report it — we re-run that firm within 48h and get back to you.
Yes. Every field on this page — profile, funds, investment criteria, portfolio and investment-team contacts — is available programmatically through the Private Equity List REST API and MCP server, so AI assistants such as Claude and ChatGPT can query Accolade Partners directly instead of scraping this page. One subscription covers both the web app and machine access — see API & MCP.
Private Equity List re-verifies investor profiles on a rolling cycle, pulling from the firm's own website and LinkedIn rather than a one-off import. This profile was last updated on 16 August, 2026. Something out of date here? Report it — we re-run that firm within 48h and get back to you.